๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy

โœ Scribed by Monica Basso; Francesco Torre; Antonino Picciotto


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
56 KB
Volume
103
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Characteristics of patients with chronic
โœ Akiko Makiyama; Yoshito Itoh; Akinori Kasahara; Yasuharu Imai; Sumio Kawata; Ken ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 88 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND The objective of the current study was to determine the characteristic features of sustained responders who develop hepatocellular carcinoma after treatment with interferon for chronic hepatitis C. ## METHODS This study included 3626 patients with chronic hepatitis C wh

Virological patterns of hepatitis C viru
โœ M S De Mitri; T Iervese; E Pisi; G Morsica; A Lazzarin ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 154 KB ๐Ÿ‘ 2 views

CORRESPONDENCE 1287 tive anions determine the potential for crystal precipi-though the location within the stone is not identified. Thus, their data would seem to confirm our findings tation within bile. Certain disease states predispose and be in conflict with the statement in their letter to supe

Predictors of a sustained beneficial res
โœ Hari S. Conjeevaram; James E. Everhart; Jay H. Hoofnagle ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 466 KB ๐Ÿ‘ 2 views

## Predictors of a Sustained Beneficial Response to Interferon Alfa Therapy in Chronic Hepatitis C Interferon alfa was first reported to have beneficial effects in chronic hepatitis C in the mid-l980s,' effects that were subsequently verified in multiple randomized controlled trials performed in

Varying incidence of cirrhosis and hepat
โœ Michiko Shindo; Arai Ken; Tadao Okuno ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB ๐Ÿ‘ 3 views

## BACKGROUND. To determine whether interferon (IFN) therapy can reduce incidence of the development of cirrhosis and hepatocellular carcinoma equally in patients with chronic hepatitis C virus (HCV) who responded differently to therapy, a retrospective analysis of 250 patients treated with IFN wa

Clinical significance of hepatic HCV RNA
โœ Larghi, Alberto; Tagger, Alessandro; Crosignani, Andrea; Ribero, Maria Lisa; Bru ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 70 KB ๐Ÿ‘ 2 views

Whether sustained biochemical response and absence of serum HCV RNA in the 6-12 months following suspension of interferon-โฃ (IFN-โฃ) therapy reflect definitive viral clearance in patients with chronic hepatitis C virus (HCV) infection is controversial. To obtain more information on this topic, HCV RN